Outcome Following Use of Different Concentrations of NaOCl as Wound Lavage and Hemostatic Agent in Partial Pulpotomy
Launched by POSTGRADUATE INSTITUTE OF DENTAL SCIENCES ROHTAK · May 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different strengths of a cleaning solution called sodium hypochlorite (NaOCl) affect the success of a dental procedure known as partial pulpotomy. This procedure is used for teeth that have a deep cavity and show signs of irreversible pulpitis, which is a painful condition where the tooth's nerve is damaged. The trial will compare the results of using 5% and 3% concentrations of NaOCl during the treatment to see which one leads to better healing and less pain for patients.
To participate in this trial, individuals should have mature permanent molars with a specific diagnosis of symptomatic irreversible pulpitis, and their teeth should be healthy in other ways, such as having no severe gum disease. Eligible participants are generally healthy adults aged between 18 and 70 years, and they must be able to control bleeding during the procedure. Those who join the study can expect to receive either concentration of the cleaning solution during their dental treatment and will be monitored for their recovery, pain levels, and overall oral health-related quality of life after the procedure. It's important to note that individuals with certain dental issues or conditions, like pregnant women, will not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Mature permanent mandibular molars.
- • 2. Teeth with clinical diagnosis of symptomatic irreversible pulpitis
- • 3. Patients having normal periapical status with periapical index (PAI) score ≤ 2
- • 4. Periodontally healthy teeth
- • 5. Patients having physical status of class 1 or 2 according to ASA classification
- • 6. Pulpal bleeding can be controlled within 6 minutes.
- • 7. Presence of extremely deep carious lesion on radiograph -
- Exclusion Criteria:
- • 1) Non restorable teeth 2) Necrotic pulp evident upon exposure 3) Negative response to vitality test 4) Presence of sinus tract 5) Presence of soft tissue swelling 6) Radiographic signs of internal or external root resorption 7) Pregnant women
- • -
About Postgraduate Institute Of Dental Sciences Rohtak
The Postgraduate Institute of Dental Sciences, Rohtak, is a premier academic institution dedicated to advancing dental education, research, and clinical practice. With a commitment to fostering innovation in oral health, the institute is actively engaged in conducting clinical trials that aim to enhance treatment methodologies and improve patient outcomes. By integrating cutting-edge research with comprehensive training, the institute plays a pivotal role in shaping the future of dental sciences, while adhering to the highest ethical standards and regulatory guidelines in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rohtak, Haryana, India
Patients applied
Trial Officials
Dr. Sanjay Tewari, MDS
Study Director
PGIDS, Rohtak, Haryana 124001
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported